Laparoscopic liver resection for hepatocellular carcinoma complicated with significant portal hypertension: A propensity score-matched survival analysis

医学 禁忌症 肝细胞癌 倾向得分匹配 危险系数 肝硬化 腹水 置信区间 门脉高压 内科学 外科 胃肠病学 比例危险模型 总体生存率 存活率 生存分析 替代医学 病理
作者
Zhangyou Guo,Hong Yuan,Bing Tu,Yao Cheng,Xiaomei Wang
出处
期刊:Hepatobiliary & Pancreatic Diseases International [Elsevier BV]
卷期号:22 (4): 358-365 被引量:1
标识
DOI:10.1016/j.hbpd.2022.03.012
摘要

Significant portal hypertension (SPH) is a relative contraindication for patients with resectable hepatocellular carcinoma (HCC). However, increasing evidence indicates that liver resection is feasible for HCC patients with SPH. HCC patients with cirrhosis who underwent laparoscopic liver resection (LLR) in two centers from January 2013 to April 2018 were included. Surgical and survival outcomes were analyzed to explore potential prognostic factors. Propensity score matching (PSM) analysis was performed to minimize bias. A total of 165 patients were divided into two groups based on the presence (SPH, n = 76) or absence (non-SPH, n = 89) of SPH. Patients in the SPH group had longer operative time, more blood loss, and more advanced TNM stage than patients in the non-SPH group (P < 0.05). However, there were no significant differences in the postoperative 90-day mortality rate (n = 0), overall postoperative complications (47.4% vs. 41.6%, P = 0.455), Clavien-Dindo classification (P = 0.347), conversion to open surgery (9.2% vs. 6.7%, P = 0.557), or length of hospitalization (16 vs. 15 days, P = 0.203) between the SPH and non-SPH groups before PSM. Similar results were obtained after PSM. The 1-, 3-, and 5-year overall survival (OS) and recurrence-free survival rates in the SPH group were not significantly different from those in the non-SPH group both before and after PSM (log-rank P > 0.05). After PSM, alpha-fetoprotein (AFP) ≥ 400 μg/L [hazard ratio (HR) = 4.71, 95% confidence interval (CI): 2.69-8.25], ascites (HR = 2.18, 95% CI: 1.30-3.66), American Society of Anesthesiologists (ASA) classification (III vs. II) (HR = 2.13, 95% CI: 1.11-4.07) and tumor diameter > 5 cm (HR = 3.91, 95% CI: 2.02-7.56) independently predicted worse OS. LLR for patients with HCC complicated with SPH appears feasible at the price of increasing operative time and blood loss. AFP, ascites, ASA classification and tumor diameter may predict the prognosis of HCC complicated with SPH after LLR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
汉堡包应助王柯采纳,获得10
2秒前
轩墨发布了新的文献求助10
2秒前
爆米花应助半糖采纳,获得10
3秒前
英姑应助孙成成采纳,获得10
3秒前
5秒前
小白菜完成签到,获得积分10
6秒前
领导范儿应助nimo采纳,获得10
8秒前
英俊的铭应助nimo采纳,获得10
8秒前
9秒前
南区食堂不好吃完成签到,获得积分10
9秒前
10秒前
11秒前
妄自完成签到,获得积分10
13秒前
SciGPT应助曦小蕊采纳,获得10
14秒前
14秒前
哆啦A梦的小小王完成签到 ,获得积分10
15秒前
热心易绿完成签到 ,获得积分10
15秒前
qi0625完成签到,获得积分10
16秒前
至幸发布了新的文献求助10
16秒前
Wait发布了新的文献求助10
16秒前
大胆问丝完成签到,获得积分20
19秒前
19秒前
科研通AI2S应助端庄的学姐采纳,获得10
20秒前
20秒前
量子星尘发布了新的文献求助10
21秒前
ACE发布了新的文献求助10
24秒前
24秒前
澡雪发布了新的文献求助10
25秒前
Wait完成签到,获得积分10
27秒前
arabidopsis应助科研通管家采纳,获得10
27秒前
在水一方应助科研通管家采纳,获得10
27秒前
Ava应助科研通管家采纳,获得10
27秒前
领导范儿应助科研通管家采纳,获得10
27秒前
情怀应助科研通管家采纳,获得10
27秒前
赘婿应助科研通管家采纳,获得10
27秒前
英俊的铭应助科研通管家采纳,获得10
27秒前
yx_cheng应助科研通管家采纳,获得10
27秒前
FashionBoy应助科研通管家采纳,获得10
27秒前
28秒前
28秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975516
求助须知:如何正确求助?哪些是违规求助? 3519930
关于积分的说明 11200130
捐赠科研通 3256278
什么是DOI,文献DOI怎么找? 1798183
邀请新用户注册赠送积分活动 877425
科研通“疑难数据库(出版商)”最低求助积分说明 806320